Author name: Yogi Raj

With over two decades of hands-on experience in regulatory affairs, Yogi Raj brings deep insight into global product approval processes and regulatory compliance. His expertise spans understanding country-specific regulatory pathways, aligning submissions with health authority expectations, and guiding pharmaceutical companies through both initial registrations and renewals. Yogi’s articles reflect practical knowledge shaped by years of working closely with regulatory bodies worldwide, helping stakeholders avoid delays and meet approval standards confidently.

DAV Introduces New Drug Registration Process in Vietnam

Pharmaceuticals

DAV Introduces New Drug Registration Process in Vietnam

Yogi Raj / March 14, 2025 / Pharmaceuticals

The regulation of drugs in Vietnam is the responsibility of the Drug Administration of Vietnam (DAV). The DAV is a […]

Biopharmaceutical Alliance

Pharmaceuticals

Biopharmaceutical Alliance Launched by India, South Korea, US, Japan, and EU

Yogi Raj / March 12, 2025 / Pharmaceuticals

The global biopharmaceutical sector has taken a significant step towards ensuring a resilient drug supply chain with the formation of

Pharmaceutical Regulations in Thailand

Pharmaceuticals, Thai FDA Compliance

Pharmaceutical Regulations in Thailand

Yogi Raj / March 11, 2025 / Pharmaceuticals, Thai FDA Compliance

The domestic pharmaceutical market in Thailand is anticipated to see a 4.5-5.0% growth in 2022 compared to the previous year.